Minimally invasive neuroscience (02172) has risen by nearly 5%, up 4.23% to HKD 8.13, with a turnover of HKD 3.3518 million at the time of publication.
According to the Wise News app, Minimally Invasive Neuroscience (02172) has risen by nearly 5%, up 4.23% to HKD 8.13, with a turnover of HKD 3.3518 million at the time of publication.
On the news front, Minimally Invasive Neuroscience announced that it is expected to achieve a net income of approximately RMB 1.3 billion to 1.5 billion in the first half of 2024, an increase of about 124% to 158% year on year.
The board of directors believes that the main reasons for the expected increase in the group's profit are: benefiting from the coverage of hospitals and the increase in market share, and the rapid growth of overseas business, the group's expected revenue for the reporting period will increase by about 34% to 37% compared with the same period last year; through the implementation of multiple supply chain improvement projects and cost optimization measures, the group's operational efficiency has been improved, and its profitability has been significantly enhanced.